查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1770812

全球儿茶素市场规模（按类型、来源、功能和应用）—区域展望、竞争策略、2034 年细分市场预测

Catechin Market Size - By Type, By Source, By Function, By Application - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 240 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计到 2034 年全球儿茶素市场规模将达到 2,761 万美元，复合年增长率为 3.66%。

限制因素：儿茶素市场面临许多重大挑战，可能阻碍其成长。主要问题是提取和加工成本高昂。由于溶剂萃取和层析法精製等先进製程所需的高能耗和复杂的基础设施，导致生产成本增加。这种定价障碍可能会限制儿茶素产品的可得性，尤其是在消费者重视价格的地区。此外，复杂的监管也构成了一项重大挑战。

本报告研究了全球儿茶素市场，并提供了区域市场规模预测、驱动因素、限制因素、机会、挑战分析和公司概况。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场动态

  • 驱动因素、限制因素、机会与挑战分析
    • 驱动程式
    • 限制因素
    • 机会
    • 任务

第五章 市场变数与展望

  • SWOT分析
  • PESTEL分析
  • 波特五力分析
  • 热图分析

第六章 竞争态势

  • 全球儿茶素市场：製造地、销售区域与介面类型分布
  • 全球儿茶素市场的併购、伙伴关係、介面推出和联盟

第七章 全球儿茶素市场规模（按类型）（2021-2034）

  • 表儿茶素
  • 表儿茶素没食子酸酯（ECG）
  • 表没食子儿茶素（EGC）
  • 表没食子儿茶素没食子酸酯 (EGCG)
  • 其他的

第八章 全球儿茶素市场规模（依来源）（2021-2034）

  • 绿茶儿茶素
  • 可可儿茶素
  • 葡萄儿茶素
  • 其他的

第九章 全球儿茶素市场规模（依功能）（2021-2034）

  • 抗氧化剂
  • 心血管健康
  • 体重管理
  • 皮肤健康
  • 消炎（药）
  • 大脑健康
  • 其他的

第 10 章 全球儿茶素市场规模（依应用） （2021-2034）

  • 机能性食品
  • 机能饮料
  • 化妆品、护肤
  • 营养补充品
  • 其他的

第 11 章全球儿茶素市场规模（2021-2034）

  • 全球儿茶素市场规模与市场占有率

第 12 章 依地区分類的全球儿茶素市场规模（2021-2034 年）

  • 亚太地区
    • 澳洲
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 欧洲
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 英国
    • 其他欧洲国家
  • 中东和非洲
    • 沙乌地阿拉伯王国
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 埃及
    • 摩洛哥
    • 奈及利亚
    • 其他中东和非洲地区
  • 北美洲
    • 加拿大
    • 墨西哥
    • 美国
  • 拉丁美洲
    • 阿根廷
    • 巴西
    • 其他拉丁美洲

第十三章 公司简介

  • Biosynth
  • Botaniex
  • Caymanchem
  • Hangzhou Qinyuan Natural Plant Technology
  • Indena
  • INDOFINE Chemical Company
  • Novanat Bioresources
  • Taiyo
  • Tata Chemicals Limited
  • Vital-Chem
  • 其他的

第十四章 结论

第 15 章简称表

第 16 章参考链接

简介目录
Product Code: FOOD2567

Catechin Market Introduction and Overview

According to SPER Market Research, 'Global Catechin Market Size - By Type, By Source, By Function, By Application - Regional Outlook, Competitive Strategies and Segment Forecast to 2034' state that the Global Catechin Market is predicted to reach 27.61 million by 2034 with a CAGR of 3.66%.

A naturally occurring component of plants, catechin belongs to the flavonoid family, specifically the flavan-3-ols subgroup. This type of antioxidant is well known for its health-promoting properties and is found in the highest concentration in green tea, chocolate, berries, and apples. Because they help the body combat harmful free radicals, catechins help reduce oxidative stress and inflammation. Epicatechin, epicatechin gallate, epigallocatechin, and epigallocatechin gallate (EGCG) are polyphenolic chemicals that come in a variety of stereoisomeric forms.

Restraints: There are several major challenges facing the catechins market that could hinder its growth. A major issue is the significant expense associated with extraction and processing. Production costs are increased by the high energy consumption and complex infrastructure required for advanced processes like solvent-based extraction and chromatographic purification. This pricing barrier may limit the availability of catechin products, especially in areas where consumers are price-sensitive. Regulatory complexity also presents significant challenges.

Scope of the report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Type, By Source, By Function, By Application

Regions covered North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered

Biosynth, Botaniex, Caymanchem, Hangzhou Qinyuan Natural Plant Technology, Indena, INDOFINE Chemical Company, Novanat Bioresources, Taiyo, Tata Chemicals Limited, Vital-Chem.

Global Catechin Market Segmentation:

By Type: Based on the Type, Global Catechin Market is segmented as; Epicatechin, Epicatechin gallate (ECG), Epigallocatechin (EGC), Epigallocatechin gallate (EGCG), Others.

By Source: Based on the Source, Global Catechin Market is segmented as; Green tea catechins, Cocoa catechins, Grape catechins, Others.

By Function: Based on the Function, Global Catechin Market is segmented as; Antioxidants, Cardiovascular health, Weight management, Skin health, Anti-inflammatory, Brain health, Others.

By Application: Based on the Application, Global Catechin Market is segmented as; Functional foods, Functional beverages, Cosmetics and skincare, Nutraceuticals, Others.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1. Research data source
    • 2.1.1. Secondary Data
    • 2.1.2. Primary Data
    • 2.1.3. SPERs internal database
    • 2.1.4. Premium insight from KOLs
  • 2.2. Market size estimation
    • 2.2.1. Top-down and Bottom-up approach
  • 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges

5. Market variable and outlook

  • 5.1. SWOT Analysis
    • 5.1.1. Strengths
    • 5.1.2. Weaknesses
    • 5.1.3. Opportunities
    • 5.1.4. Threats
  • 5.2. PESTEL Analysis
    • 5.2.1. Political Landscape
    • 5.2.2. Economic Landscape
    • 5.2.3. Social Landscape
    • 5.2.4. Technological Landscape
    • 5.2.5. Environmental Landscape
    • 5.2.6. Legal Landscape
  • 5.3. PORTERs Five Forces
    • 5.3.1. Bargaining power of suppliers
    • 5.3.2. Bargaining power of buyers
    • 5.3.3. Threat of Substitute
    • 5.3.4. Threat of new entrant
    • 5.3.5. Competitive rivalry
  • 5.4. Heat Map Analysis

6. Competitive Landscape

  • 6.1. Global Catechin Market Manufacturing Base Distribution, Sales Area, Interface Type
  • 6.2. Mergers & Acquisitions, Partnerships, Interface Launch, and Collaboration in Global Catechin Market

7. Global Catechin Market, By Type 2021-2034 (USD Million)

  • 7.1. Epicatechin
  • 7.2. Epicatechin gallate (ECG)
  • 7.3. Epigallocatechin (EGC)
  • 7.4. Epigallocatechin gallate (EGCG)
  • 7.5. Others

8. Global Catechin Market, By Source 2021-2034 (USD Million)

  • 8.1. Green tea catechins
  • 8.2. Cocoa catechins
  • 8.3. Grape catechins
  • 8.4. Others

9. Global Catechin Market, By Function 2021-2034 (USD Million)

  • 9.1. Antioxidants
  • 9.2. Cardiovascular health
  • 9.3. Weight management
  • 9.4. Skin health
  • 9.5. Anti-inflammatory
  • 9.6. Brain health
  • 9.7. Others

10. Global Catechin Market, By Application 2021-2034 (USD Million)

  • 10.1. Functional foods
  • 10.2. Functional beverages
  • 10.3. Cosmetics and skincare
  • 10.4. Nutraceuticals
  • 10.5. Others

11. Global Catechin Market, 2021-2034 (USD Million)

  • 11.1. Global Catechin Market Size and Market Share

12. Global Catechin Market, By Region, 2021-2034 (USD Million)

  • 12.1. Asia-Pacific
    • 12.1.1. Australia
    • 12.1.2. China
    • 12.1.3. India
    • 12.1.4. Japan
    • 12.1.5. South Korea
    • 12.1.6. Rest of Asia-Pacific
  • 12.2. Europe
    • 12.2.1. France
    • 12.2.2. Germany
    • 12.2.3. Italy
    • 12.2.4. Spain
    • 12.2.5. United Kingdom
    • 12.2.6. Rest of Europe
  • 12.3. Middle East and Africa
    • 12.3.1. Kingdom of Saudi Arabia
    • 12.3.2. United Arab Emirates
    • 12.3.3. Qatar
    • 12.3.4. South Africa
    • 12.3.5. Egypt
    • 12.3.6. Morocco
    • 12.3.7. Nigeria
    • 12.3.8. Rest of Middle-East and Africa
  • 12.4. North America
    • 12.4.1. Canada
    • 12.4.2. Mexico
    • 12.4.3. United States
  • 12.5. Latin America
    • 12.5.1. Argentina
    • 12.5.2. Brazil
    • 12.5.3. Rest of Latin America

13. Company Profile

  • 13.1. Biosynth
    • 13.1.1. Company details
    • 13.1.2. Financial outlook
    • 13.1.3. Interface summary
    • 13.1.4. Recent developments
  • 13.2. Botaniex
    • 13.2.1. Company details
    • 13.2.2. Financial outlook
    • 13.2.3. Interface summary
    • 13.2.4. Recent developments
  • 13.3. Caymanchem
    • 13.3.1. Company details
    • 13.3.2. Financial outlook
    • 13.3.3. Interface summary
    • 13.3.4. Recent developments
  • 13.4. Hangzhou Qinyuan Natural Plant Technology
    • 13.4.1. Company details
    • 13.4.2. Financial outlook
    • 13.4.3. Interface summary
    • 13.4.4. Recent developments
  • 13.5. Indena
    • 13.5.1. Company details
    • 13.5.2. Financial outlook
    • 13.5.3. Interface summary
    • 13.5.4. Recent developments
  • 13.6. INDOFINE Chemical Company
    • 13.6.1. Company details
    • 13.6.2. Financial outlook
    • 13.6.3. Interface summary
    • 13.6.4. Recent developments
  • 13.7. Novanat Bioresources
    • 13.7.1. Company details
    • 13.7.2. Financial outlook
    • 13.7.3. Interface summary
    • 13.7.4. Recent developments
  • 13.8. Taiyo
    • 13.8.1. Company details
    • 13.8.2. Financial outlook
    • 13.8.3. Interface summary
    • 13.8.4. Recent developments
  • 13.9. Tata Chemicals Limited
    • 13.9.1. Company details
    • 13.9.2. Financial outlook
    • 13.9.3. Interface summary
    • 13.9.4. Recent developments
  • 13.10. Vital-Chem
    • 13.10.1. Company details
    • 13.10.2. Financial outlook
    • 13.10.3. Interface summary
    • 13.10.4. Recent developments
  • 13.11. Others

14. Conclusion

15. List of Abbreviations

16. Reference Links